Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine. | Front Neurol;7: 167, 2016. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.

Blokland, Arjan; Sambeth, Anke; Prickaerts, Jos; Riedel, Wim J.

Affiliation

Blokland A; Maastricht University , Maastricht , Netherlands.
Sambeth A; Maastricht University , Maastricht , Netherlands.
Prickaerts J; Maastricht University , Maastricht , Netherlands.
Riedel WJ; Maastricht University , Maastricht , Netherlands.

Front Neurol ; 7: 167, 2016.

Article in En | MEDLINE | ID: mdl-27746762

Key words

Alzheimer; actelylcholine; cognition enhancer; deficit model; memory

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Neurol Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Neurol Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: Switzerland